QCM Cayman Ltd. acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 872 shares of the pharmaceutical company’s stock, valued at approximately $252,000. Vertex Pharmaceuticals […]
Vaughan Nelson Investment Management L.P. lowered its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 5.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 478,138 shares of the pharmaceutical company’s stock after selling 26,123 shares during the period. Vertex […]
Comerica Bank increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 9.0% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 38,736 shares of the pharmaceutical company’s stock after buying an additional 3,190 shares during the quarter. Comerica Bank’s holdings in Vertex Pharmaceuticals were worth […]
Foster Victor Wealth Advisors LLC trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 4.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,242 shares of the pharmaceutical company’s stock after selling 609 shares during the quarter. Foster Victor Wealth Advisors […]
McAdam LLC lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 6.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,954 shares of the pharmaceutical company’s stock after buying an additional 186 shares during the quarter. McAdam LLC’s holdings […]